Heska Corp (HSKA.W)
HSKA.W on CBOE When Trading NASDAQ Global Select Market
8.87USD
10 Apr 2013
8.87USD
10 Apr 2013
Price Change (% chg)
$0.82 (+10.19%)
$0.82 (+10.19%)
Prev Close
$8.05
$8.05
Open
$8.87
$8.87
Day's High
$8.87
$8.87
Day's Low
$8.87
$8.87
Volume
100
100
Avg. Vol
2
2
52-wk High
$11.37
$11.37
52-wk Low
$7.76
$7.76
About
Heska Corporation develops, manufactures, markets, sells and supports veterinary products. The Company is focused on the canine and feline companion animal health markets. It operates in two segments: Core Companion Animal Health and Other Vaccines, Pharmaceuticals and Products. The Core Companion Animal Health segment (CCA)... (more)
Overall
| Beta: | 1.65 |
| Market Cap (Mil.): | $47.01 |
| Shares Outstanding (Mil.): | 5.80 |
| Dividend: | 0.10 |
| Yield (%): | 4.94 |
Financials
| HSKA.W | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 36.87 | 30.63 | 35.83 |
| EPS (TTM): | 0.22 | -- | -- |
| ROI: | 2.29 | 10.42 | 18.72 |
| ROE: | 2.47 | 13.40 | 19.54 |
Competitors
| Price | Change | |
|---|---|---|
| Pfizer Inc. (PFE.N) | $28.96 | -0.29 |
| Novartis AG (NOVN.VX) | CHF71.75 | -0.45 |
| Merck & Co., Inc. (MRK.N) | $45.99 | -0.38 |
| Bayer AG (BAYGn.DE) | €83.79 | -1.01 |
| Bayer AG (BAYE.F) | -- | -- |
| Sanofi SA (SASY.PA) | €84.50 | -0.12 |
| Eli Lilly & Co. (LLY.N) | $55.90 | -0.04 |
| IDEXX Laboratories, Inc. (IDXX.OQ) | $86.40 | -0.20 |
| Virbac SA (VIRB.PA) | €166.30 | +1.30 |
| Vetoquinol SA (VETO.PA) | €27.75 | +0.85 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$127.00
|
|
Provider: TheStreet.com Ratings
|
$10.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

